Our studies provide important insight into signaling deregulation of the SREBP1- caspase-7 axis in the chemosensitivity of colon cancer, and also help elucidate the role of SREBP1as a therapeutic intervention target in CRC treatment. This evidence concerns the gene SREBF1 and malignant colon neoplasm.